Ginkgo Bioworks insider sells shares to cover taxes
Ginkgo Bioworks Holdings, Inc. director and officer Reshma P. Shetty, reporting indirect holdings "by spouse," disclosed PSU vesting and related share sales.
Rhea-AI Filing Summary
Ginkgo Bioworks Holdings, Inc. director and officer Reshma P. Shetty, reporting indirect holdings "by spouse," disclosed PSU vesting and related share sales. On April 7–8, 2026, her spouse exercised 55,476 performance-based restricted stock units at $0.00 per unit into Class A Common Stock.
On April 8 and 9, 2026, a total of 26,271 Class A shares were sold in open-market transactions at prices of $6.93 and $6.397 per share to cover tax withholding obligations tied to the PSU vesting, which the footnotes state were not discretionary trades. After these transactions, the spouse’s indirect Class A Common Stock holdings were 338,568 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 13,116 | $6.397 | $84K |
| Exercise | Performance-Based Restricted Stock Unit | 27,738 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 27,738 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 13,155 | $6.93 | $91K |
| Exercise | Performance-Based Restricted Stock Unit | 27,738 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 27,738 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. Represents shares sold by the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
- F3. On June 19, 2025, the Reporting Person's spouse was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors.
Key Figures
Key Terms
Performance-Based Restricted Stock Unit financial
sell to cover financial
equity incentive plans financial
cash flow reduction target financial
Compensation Committee financial
FAQ
What did Ginkgo Bioworks (DNA) insider Reshma Shetty report on this Form 4?
How many Ginkgo Bioworks (DNA) PSUs vested in this transaction?
How were the Ginkgo Bioworks (DNA) PSUs for the insider’s spouse originally granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.